Kiniksa Pharmaceuticals
Dan Girard possesses extensive experience in quality assurance and regulatory compliance within the pharmaceutical and biotechnology industries. Currently serving as VP and Head of Quality at Kiniksa Pharmaceuticals since April 2019, responsibilities include overseeing clinical and commercial quality assurance and quality control. Previous roles include Executive Director of QA, where Dan developed compliance standards to ensure patient safety and regulatory adherence, and Senior Director in GMP QA. Experience prior to Kiniksa includes Principal Consultant at Medfield Consulting, Director of Quality at Genzyme, Associate Director of Quality at MedImmune, and various quality management positions at GlaxoSmithKline and Merck & Co. Dan holds an education from Dartmouth College and Saint Ignatius College Prep.
This person is not in any teams
Kiniksa Pharmaceuticals
2 followers
Kiniksa is a publicly traded biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.